MET Adds Cancer Support Benefit to Upgrade Critical Illness Plan

Core Insights - MetLife, Inc. is enhancing its Critical Illness Insurance by introducing a Cancer Support benefit in collaboration with Private Health Management, effective January 1, 2026 [1][8] - The new benefit includes access to oncology experts, care coordination, and patient counseling, aimed at helping policyholders navigate cancer treatment [2][8] - Employers utilizing these services have reported reduced case costs, fewer unnecessary treatments, and improved survival rates for late-stage cancers [3][4] Company Strategy - The introduction of the Cancer Support benefit aligns with MetLife's strategy to strengthen its Group Benefits business, potentially increasing enrollment in Critical Illness Insurance and raising premium income [5] - The Group Benefits segment, which includes critical illness insurance, has seen a 2.2% year-over-year increase in premiums during the first half of 2025 [5] - MetLife employs product launches, acquisitions, and partnerships to enhance its offerings and expand its market presence [6] Market Performance - MetLife's shares have increased by 2.3% over the past three months, outperforming the industry growth of 1.1% [7] - The company currently holds a Zacks Rank of 3 (Hold) [7]